Skip to main content
. 2017 Nov-Dec;7(6):531–541.

Table 2.

Percentage of changes in day wheeze (DW), exercise wheeze (EW), FEV1, and NO2- at time I relative to time O (I/O), time II relative to time O (II/O) and, time II relative to time I (II/I) in treated groups

Time Group DW EW FEV 1 NO 2-
I/O P -25±35.36
-53.33±50.18
-66.67±37.68*
-51.67±47.43
100±0.00
-36.67±20.49***
-26.67±23.83***
-53.33±37.52***
-6.05 ±12.51
7.9±7.16 **
9.84±19.68*
15.17±15.74***
14.05±64.02
-4.33±37.79
-4.23±8.91
-6.39±12.64
Z low
Z high
C
II/O P -10±31.62
-63.33±48.30*
-70.00±35.83**
-61.67±45.85*
100 ±0.00
-43.33±23.83*** +
-31.67±22.84***++
-73.33±28.54***
-12.98±19.81
8.91±6.36**
12.28±9.88***
19.21±16.49***
-3.80±28.72
-5.59±37.03
-16.77±12.85
-29.46±18.19*
Z low
Z high
C
II/I P 20±63.25
-10.00±31.62
-5.00±15.81
-15.00±33.75
0.00±0.00
-10±21.08
-30±34.96
-25±42.49

-6.47±17.39
1.01±3.17
3.72±11.7
3.56±4.91
-6.65±20.18
-1.33±11.59++
-13.15±9.61
-23.95±20.34
Z low
Z high
C

The results are presented as mean ± SD. Statistical comparisons were performed using independent T-test.

P: Placebo group; Z low group were treated with 5 mg/kg/day of the extract; Z high group were treated with 10 mg/kg/day of the extract; C group were treated with 1.2 mg/kg/day carvacrol.

*

p<0.05,

**

p<0.01, and

***

p<0.001, show significant differences as compared to group P.

+

p<0.05, and

++

p<0.01, show significant differences as compared to group C